Tag

Adhish Patil

2 articles

Aarti Drugs Q2 FY27 Revenue Up 27% YoY

Aarti Drugs reported Q2 FY27 consolidated net revenue of ₹826.2 crore, a 27% YoY increase, with record quarterly EBITDA of ₹137.9 crore. EBITDA margin expanded 370 bps YoY to 16.6%, the highest in nea

Aarti Drugs Q2 PAT Surges 83% to ₹82.8 Crore

Aarti Drugs reported unaudited consolidated Q2 FY27 results with revenue of ₹828.8 crore, up 27% YoY, and PAT of ₹82.8 crore, up 83% YoY. EBITDA margin expanded 370 bps YoY to 16.6%, the highest in ne